Document is current
Any future updates will be listed below
-
Authors
Ramzy, George M.
Norkin, Maxim
Koessler, Thibaud
Voirol, Lionel
Tihy, Mathieu
Hany, Dina
McKee, Thomas
Ris, Frédéric
Buchs, Nicolas
Docquier, Mylène
Toso, Christian
Rubbia-Brandt, Laura
Bakalli, Gaetan
Guerrier, Stéphane
Huelsken, Joerg
Nowak-Sliwinska, Patrycja https://orcid.org/0000-0002-8299-0444
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_197878)
H2020 European Research Council (ERC-StG-680209)
University of Geneva
- License Information
-
More Information
Article History
Received: 17 January 2023
Accepted: 20 March 2023
First Online: 3 April 2023
Declarations
:
: The study methodologies with the patient-derived tissues were approved by the Swiss Ethics Committee on research involving humans (2017–00364). The study methodologies conformed to the standards set by the Declaration of Helsinki. The experiments were undertaken with the understanding and written consent of each patient. All procedures including animal use were performed in accordance with the Institutional Ethical Committee of Animal Care in Geneva and the Swiss Cantonal Veterinary Office (34582).
: Not applicable.
: P.N.-S. is inventor of a patent of drug combination optimization methods. The other authors declare no competing interests.
